198 related articles for article (PubMed ID: 21444752)
1. CRSBP-1/LYVE-1 ligands disrupt lymphatic intercellular adhesion by inducing tyrosine phosphorylation and internalization of VE-cadherin.
Hou WH; Liu IH; Tsai CC; Johnson FE; Huang SS; Huang JS
J Cell Sci; 2011 Apr; 124(Pt 8):1231-44. PubMed ID: 21444752
[TBL] [Abstract][Full Text] [Related]
2. Development of the LYVE-1 gene with an acidic-amino-acid-rich (AAAR) domain in evolution is associated with acquisition of lymph nodes and efficient adaptive immunity.
Huang SS; Li YW; Wu JL; Johnson FE; Huang JS
J Cell Physiol; 2018 Apr; 233(4):2681-2692. PubMed ID: 28833090
[TBL] [Abstract][Full Text] [Related]
3. CRSBP-1/LYVE-1 ligands stimulate contraction of the CRSBP-1-associated ER network in lymphatic endothelial cells.
Hou WH; Liua IH; Huang SS; Huang JS
FEBS Lett; 2012 May; 586(10):1480-7. PubMed ID: 22673514
[TBL] [Abstract][Full Text] [Related]
4. CRSBP-1/LYVE-l-null mice exhibit identifiable morphological and functional alterations of lymphatic capillary vessels.
Huang SS; Liu IH; Smith T; Shah MR; Johnson FE; Huang JS
FEBS Lett; 2006 Nov; 580(26):6259-68. PubMed ID: 17070806
[TBL] [Abstract][Full Text] [Related]
5. PKCα activation of p120-catenin serine 879 phospho-switch disassembles VE-cadherin junctions and disrupts vascular integrity.
Vandenbroucke St Amant E; Tauseef M; Vogel SM; Gao XP; Mehta D; Komarova YA; Malik AB
Circ Res; 2012 Aug; 111(6):739-49. PubMed ID: 22798526
[TBL] [Abstract][Full Text] [Related]
6. Src-induced tyrosine phosphorylation of VE-cadherin is not sufficient to decrease barrier function of endothelial monolayers.
Adam AP; Sharenko AL; Pumiglia K; Vincent PA
J Biol Chem; 2010 Mar; 285(10):7045-55. PubMed ID: 20048167
[TBL] [Abstract][Full Text] [Related]
7. VE-PTP maintains the endothelial barrier via plakoglobin and becomes dissociated from VE-cadherin by leukocytes and by VEGF.
Nottebaum AF; Cagna G; Winderlich M; Gamp AC; Linnepe R; Polaschegg C; Filippova K; Lyck R; Engelhardt B; Kamenyeva O; Bixel MG; Butz S; Vestweber D
J Exp Med; 2008 Nov; 205(12):2929-45. PubMed ID: 19015309
[TBL] [Abstract][Full Text] [Related]
8. Proline-rich tyrosine kinase 2 (Pyk2) mediates vascular endothelial-cadherin-based cell-cell adhesion by regulating beta-catenin tyrosine phosphorylation.
van Buul JD; Anthony EC; Fernandez-Borja M; Burridge K; Hordijk PL
J Biol Chem; 2005 Jun; 280(22):21129-36. PubMed ID: 15778498
[TBL] [Abstract][Full Text] [Related]
9. Dynamic Regulation of Vascular Permeability by Vascular Endothelial Cadherin-Mediated Endothelial Cell-Cell Junctions.
Rho SS; Ando K; Fukuhara S
J Nippon Med Sch; 2017; 84(4):148-159. PubMed ID: 28978894
[TBL] [Abstract][Full Text] [Related]
10. VE-cadherin status as an indicator of microvascular permeability.
Monaghan-Benson E; Burridge K
Methods Mol Biol; 2013; 1046():335-42. PubMed ID: 23868598
[TBL] [Abstract][Full Text] [Related]
11. The tyrosine phosphatase SHP2 regulates recovery of endothelial adherens junctions through control of β-catenin phosphorylation.
Timmerman I; Hoogenboezem M; Bennett AM; Geerts D; Hordijk PL; van Buul JD
Mol Biol Cell; 2012 Nov; 23(21):4212-25. PubMed ID: 22956765
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial-cadherin stabilizes at cell-cell junctions by anchoring to circumferential actin bundles through alpha- and beta-catenins in cyclic AMP-Epac-Rap1 signal-activated endothelial cells.
Noda K; Zhang J; Fukuhara S; Kunimoto S; Yoshimura M; Mochizuki N
Mol Biol Cell; 2010 Feb; 21(4):584-96. PubMed ID: 20032304
[TBL] [Abstract][Full Text] [Related]
13. Contact inhibition of VEGF-induced proliferation requires vascular endothelial cadherin, beta-catenin, and the phosphatase DEP-1/CD148.
Grazia Lampugnani M; Zanetti A; Corada M; Takahashi T; Balconi G; Breviario F; Orsenigo F; Cattelino A; Kemler R; Daniel TO; Dejana E
J Cell Biol; 2003 May; 161(4):793-804. PubMed ID: 12771128
[TBL] [Abstract][Full Text] [Related]
14. Tyrosine phosphorylation of VE-cadherin and claudin-5 is associated with TGF-β1-induced permeability of centrally derived vascular endothelium.
Shen W; Li S; Chung SH; Zhu L; Stayt J; Su T; Couraud PO; Romero IA; Weksler B; Gillies MC
Eur J Cell Biol; 2011 Apr; 90(4):323-32. PubMed ID: 21168935
[TBL] [Abstract][Full Text] [Related]
15. NHERF links the N-cadherin/catenin complex to the platelet-derived growth factor receptor to modulate the actin cytoskeleton and regulate cell motility.
Theisen CS; Wahl JK; Johnson KR; Wheelock MJ
Mol Biol Cell; 2007 Apr; 18(4):1220-32. PubMed ID: 17229887
[TBL] [Abstract][Full Text] [Related]
16. Plakoglobin maintains the integrity of vascular endothelial cell junctions and regulates VEGF-induced phosphorylation of VE-cadherin.
Muramatsu F; Kidoya H; Naito H; Hayashi Y; Iba T; Takakura N
J Biochem; 2017 Jul; 162(1):55-62. PubMed ID: 28158602
[TBL] [Abstract][Full Text] [Related]
17. The integrin antagonist cilengitide activates alphaVbeta3, disrupts VE-cadherin localization at cell junctions and enhances permeability in endothelial cells.
Alghisi GC; Ponsonnet L; Rüegg C
PLoS One; 2009; 4(2):e4449. PubMed ID: 19212436
[TBL] [Abstract][Full Text] [Related]
18. Endothelial permeability and VE-cadherin: a wacky comradeship.
Gavard J
Cell Adh Migr; 2013; 7(6):455-61. PubMed ID: 24430214
[TBL] [Abstract][Full Text] [Related]
19. Urocortin increased LPS-induced endothelial permeability by regulating the cadherin-catenin complex via corticotrophin-releasing hormone receptor 2.
Wan R; Guo R; Chen C; Jin L; Zhu C; Zhang Q; Xu Y; Li S
J Cell Physiol; 2013 Jun; 228(6):1295-303. PubMed ID: 23168683
[TBL] [Abstract][Full Text] [Related]
20. S-nitrosylation regulates VE-cadherin phosphorylation and internalization in microvascular permeability.
Guequén A; Carrasco R; Zamorano P; Rebolledo L; Burboa P; Sarmiento J; Boric MP; Korayem A; Durán WN; Sánchez FA
Am J Physiol Heart Circ Physiol; 2016 Apr; 310(8):H1039-44. PubMed ID: 26921435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
